Enliven Therapeutics (ELVN)
NASDAQ:ELVN
US Market
Holding ELVN?
Track your performance easily

Enliven Therapeutics (ELVN) Technical Analysis

285 Followers

Technical Sentiment

Overall Consensus
Strong Buy
16Bullish
6Neutral
0Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Enliven Therapeutics’s (ELVN) Moving Averages Convergence Divergence (MACD) indicator is 0.70, suggesting Enliven Therapeutics is a Buy.
Enliven Therapeutics’s (ELVN) 20-Day exponential moving average is 28.14, while Enliven Therapeutics’s (ELVN) share price is $28.96, making it a Buy.
Enliven Therapeutics’s (ELVN) 50-Day exponential moving average is 26.57, while Enliven Therapeutics’s (ELVN) share price is $28.96, making it a Buy.

Enliven Therapeutics (ELVN) Pivot Points

Nov 10, 2024, 02:51 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
27.65
28.24
28.62
29.20
29.58
30.17
30.55
Fibonacci
28.24
28.61
28.83
29.20
29.57
29.80
30.17
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Enliven Therapeutics (ELVN) Moving Averages

Nov 10, 2024, 02:51 AM
Period
Simple
Exponential
MA5
28.63Buy
28.76Buy
MA10
28.42Buy
28.57Buy
MA20
28.48Buy
28.14Buy
MA50
25.86Buy
26.57Buy
MA100
24.48Buy
24.72Buy
MA200
21.62Buy
21.40Buy
Enliven Therapeutics’s (ELVN) 10-Day exponential moving average is 28.57, while Enliven Therapeutics’s (ELVN) share price is $28.96, making it a Buy.
Enliven Therapeutics’s (ELVN) 100-Day exponential moving average is 24.72, while Enliven Therapeutics’s (ELVN) share price is $28.96, making it a Buy.
Enliven Therapeutics’s (ELVN) stock price is $28.96 and Enliven Therapeutics’s (ELVN) 50-day simple moving average is 25.86, creating a Buy signal.
Enliven Therapeutics’s (ELVN) stock price is $28.96 and Enliven Therapeutics’s (ELVN) 100-day simple moving average is 24.48, creating a Buy signal.
Enliven Therapeutics’s (ELVN) stock price is $28.96 and Enliven Therapeutics’s (ELVN) 200-day simple moving average is 21.62, creating a Buy signal.

Enliven Therapeutics (ELVN) Technical Indicators

Nov 10, 2024, 02:51 AM
Name
Value
Implied Action
RSI (14)
61.82
Neutral
STOCH (9,6)
79.65
Neutral
STOCHRSI (14)
76.21
Neutral
MACD (12,26)
0.70
Buy
ADX (14)
28.20
Neutral
Williams %R
-28.70
Buy
CCI (14)
60.75
Neutral
ATR (14)
1.14
-
Ultimate Oscillator
54.38
Neutral
ROC
0.31
Buy
Enliven Therapeutics’s (ELVN) Relative Strength Index (RSI) is 61.82, creating a Neutral signal.
Enliven Therapeutics’s (ELVN) Trend Strength Indicator (ADX) is 28.20, creating a Neutral signal.
Enliven Therapeutics’s (ELVN) Commodity Channel Index (CCI) is 60.75, creating a Neutral signal.
Enliven Therapeutics’s (ELVN) Price Rate of Change (ROC) is 0.31, creating a Buy signal.

FAQ

Is ELVN a Buy, Hold, or Sell?
Based on ELVN’s technical indicators, ELVN is a Strong Buy.
    What is ELVN’s RSI (14)?
    ELVN’s RSI (14) is 61.82, which suggests ELVN is a Neutral.
      What is ELVN’s MACD?
      ELVN’s MACD is 0.70, which suggests ELVN is a Buy.
        What is ELVN’s 5-day moving average?
        ELVN’s 5-day moving average is 28.63, which suggests ELVN is a Buy.
          What is ELVN’s 20-day moving average?
          ELVN 20-day moving average is 28.48, which suggests ELVN is a Buy.
            What is ELVN’s 50-day moving average?
            ELVN’s 50-day moving average is 25.86, which suggests ELVN is a Buy.
              What is ELVN’s 200-day moving average?
              ELVN’s 200-day moving average is 21.62, which suggests ELVN is a Buy.
                What is ELVN’s Williams % R (14)?
                ELVN’s Williams % R (14) is -28.70, which suggests ELVN is a Buy.
                  What is ELVN’s CCI (14)?
                  ELVN’s CCI (14) is 60.75, which suggests ELVN is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis